In 1951, a poor African American woman named Henrietta Lacks walked into the outpatient clinic at Johns Hopkins Hospital in Baltimore complaining of a “knot” on her womb. She was diagnosed with an aggressive form of cervical cancer and, during her treatment, a sample of her tumor was taken without her knowledge or consent. Those cells—later named HeLa cells—became the first immortal human cell line, transforming medical research forever. Yet for decades, Henrietta’s identity and her family’s story remained hidden. Her case now stands as a landmark for both scientific breakthrough and ethical accountability.

Who Was Henrietta Lacks?

Henrietta Lacks was born Loretta Pleasant on August 1, 1920, in Roanoke, Virginia, to Eliza and John Randall Pleasant. When she was four, her mother died, and her father moved the family back to his hometown of Halifax County, Virginia. Unable to care for all his children, he split them among relatives. Henrietta went to live with her grandfather, Tommy Lacks, in a log cabin that had once been a slave quarters on a plantation. There she shared a room with her cousin David “Day” Lacks, who would later become her husband. Henrietta grew up working on the tobacco farm, attending school only through the sixth grade. In 1941, she and Day moved to Baltimore, where Day found work at the Bethlehem Steel shipyard. Henrietta had five children, the first born when she was just 14, and she dedicated herself to raising her family while also helping with the farm.

In January 1951, Henrietta noticed unusual spotting and discomfort in her abdomen. She was referred to the gynecology clinic at Johns Hopkins, one of the few hospitals in the Baltimore area that treated African American patients during the era of segregation. After a biopsy revealed a malignant cervical tumor, Henrietta underwent radium treatment, the standard therapy at the time. But the cancer was aggressive, and she died on October 4, 1951, at the age of 31. What Henrietta did not know—and what her family would not learn for more than 20 years—was that a small piece of her tumor had been kept alive and multiplying in a laboratory.

The Discovery of HeLa Cells: A Scientific Breakthrough

Before Henrietta Lacks, scientists had struggled for decades to keep human cells alive outside the body. Normal cells would divide a limited number of times and then die. But the cells taken from Henrietta’s tumor were different. Dr. George Gey, the head of tissue culture research at Johns Hopkins, discovered that these cells could not only survive but proliferate indefinitely under the right conditions. They did not suffer from the senescence that stops ordinary cells from growing, making them effectively “immortal.” Gey had been trying to grow cells from any human tissue for years, but all previous attempts failed. Henrietta’s cancer cells, however, continued to divide every 24 hours with no sign of stopping.

Gey named the cell line “HeLa” after the first two letters of Henrietta’s first and last name. HeLa cells were soon distributed to researchers around the world at no charge—Gey believed in sharing scientific resources freely. They became the first standardized human cell line, allowing labs everywhere to perform experiments that had previously been impossible. The importance of HeLa cells can hardly be overstated: they were used in the development of the polio vaccine, in cancer research, in studying the effects of radiation and toxins, and in unlocking the secrets of human genetics. Today, HeLa cells are one of the most commonly used lines in biomedical research, with more than 110,000 scientific papers citing their use.

How HeLa Cells Became Immortal

The secret behind HeLa cells’ immortality lies in their genetic makeup. Henrietta’s tumor was caused by the human papillomavirus (HPV), which inserted its own DNA into her cells, inactivating the tumor suppressor gene p53. This loss of p53, along with the activation of the enzyme telomerase, allowed the cells to continuously replicate without the normal cellular aging process. Unlike normal cells, which have a limited number of divisions (the Hayflick limit), HeLa cells can divide indefinitely as long as they are provided with nutrients and a suitable environment. This unique property made them the perfect workhorse for laboratories globally.

Major Medical Advances Made Possible by HeLa Cells

HeLa cells have been a crucial tool in countless scientific discoveries. Here are some of the most notable:

  • Polio vaccine: In the early 1950s, Jonas Salk needed to test his inactivated polio vaccine on a massive scale. HeLa cells, which could be grown cheaply and reliably in large quantities, provided the perfect testing platform. The success of the polio vaccine trials using HeLa cells led to the near eradication of polio worldwide.
  • Cancer research: HeLa cells helped reveal how cancer cells divide uncontrollably and how certain viruses, such as HPV, can trigger cancer. The discovery of the link between HPV and cervical cancer—which won Harald zur Hausen the Nobel Prize in 2008—relied heavily on HeLa cells.
  • HIV/AIDS studies: Researchers infected HeLa cells with HIV to study how the virus replicates and to test potential treatments. The cells also helped identify the CD4 receptor as the entry point for the virus, a critical step in understanding HIV pathogenesis.
  • Genome mapping and gene expression: In 2013, the complete genome of the HeLa cell line was published, providing a reference for understanding how mutations in human cells contribute to disease. However, that publication also raised new privacy concerns for the Lacks family, as it revealed genetic information that could be linked back to Henrietta's descendants.
  • Drug development and toxicology: HeLa cells are routinely used to test the toxicity of new compounds and to study the effects of radiation and chemotherapeutic agents. They have also been used in research on tuberculosis, atherosclerosis, and the effects of microgravity on human cells—HeLa cells have even been sent into space.

The story of Henrietta Lacks is not just a triumph of science; it is a profound cautionary tale about medical ethics. In the 1950s, patient consent was not considered necessary for using tissue samples in research. Doctors at Johns Hopkins took Henrietta’s cells without informing her or her family. For more than two decades, the Lacks family had no idea that Henrietta’s cells had become a multi‑million‑dollar industry. Companies commercialized HeLa cells, and researchers patented them—all while Henrietta’s own children struggled to afford health insurance. The family lived in poverty, and some could not access basic medical care, despite the fact that Henrietta’s cells were being used in laboratories around the world.

When the truth finally emerged in the mid‑1970s, the family was shocked and angry. A reporter contacted them for a story about HeLa cells, and only then did they learn that Henrietta’s cells were still alive. They felt exploited and used. The lack of informed consent violated basic human dignity. This case helped spark the modern movement for patient autonomy and ethical oversight in medical research.

The ethical shortcomings of the HeLa case contributed directly to the development of informed consent guidelines. In 1979, the U.S. government issued the Belmont Report, which established three core principles: respect for persons, beneficence, and justice. Respect for persons requires that individuals be treated as autonomous agents and that those with diminished autonomy be protected. Beneficence obligates researchers to maximize benefits and minimize harm. Justice requires that the burdens and benefits of research be distributed fairly. These principles now underpin all federally funded research involving human subjects.

Despite these changes, the HeLa case remains a stark reminder that ethical standards evolve over time and that safeguards must be constantly reinforced. Recent controversies over using patient data without explicit consent show that the issues raised by Henrietta’s story are far from resolved. The case also highlighted the intersection of race and medicine: Henrietta was a Black woman treated during Jim Crow, and the exploitation of her cells mirrors a long history of medical abuses against African Americans, including the Tuskegee syphilis study and forced sterilizations.

The Lacks Family’s Struggle for Recognition and Justice

For decades, the Lacks family was denied any recognition or compensation for the cells that had become a cornerstone of modern biomedical science. Henrietta’s descendants lived in poverty while her cells generated enormous profits for pharmaceutical and biotech companies. In 2010, Rebecca Skloot published The Immortal Life of Henrietta Lacks, a book that brought the story to global attention and ignited a public conversation about race, ethics, and medical research. The book became a bestseller and was later adapted into an HBO film starring Oprah Winfrey.

The book’s popularity led to increased scrutiny of the handling of HeLa cells. In 2013, the National Institutes of Health (NIH) reached an agreement with the Lacks family to give them a voice in how HeLa genomic data is used. The family now serves on a data access committee that reviews applications from researchers who wish to study the full genome sequence. This was a historic step toward recognizing the rights of individuals whose biological materials are used in research. However, the agreement did not include financial compensation.

In 2021, the family continued their fight by filing a lawsuit against a biotech company that had used HeLa cells without permission. That lawsuit was dismissed, but it nevertheless highlighted the ongoing struggle for equitable treatment and the need for clearer legal frameworks around human biological materials. The family has also advocated for stronger consent laws and has spoken at universities and conferences about the importance of bioethics.

The Henrietta Lacks Foundation

In honor of her legacy, the Henrietta Lacks Foundation was established to provide educational scholarships and health assistance to Henrietta’s descendants and to other families who have been affected by similar unethical research practices. The foundation aims to turn a story of exploitation into one of empowerment and restitution. It also funds community health initiatives and educational programs about informed consent.

Broader Impact on Medical Ethics and Research Policy

The contributions of Henrietta Lacks extend far beyond the laboratory. Her story has influenced major policy changes and reshaped how scientists think about the people behind the cells. Some of the most important impacts include:

  • Informed consent reforms: Today, it is standard practice to obtain written informed consent from patients before using their tissue for research. This is required by federal regulations under the Common Rule, which was revised in 2018 to strengthen consent requirements for biospecimens. The revisions mandate that researchers must obtain consent for the use of identifiable data and biospecimens, though there are exceptions for de‑identified samples.
  • Privacy protections: The HeLa genome sequencing controversy prompted the NIH to develop new policies that respect the privacy of individuals whose genomic data is used. The Lacks family’s involvement in data governance sets a precedent for community engagement in research oversight. In 2013, the NIH and the family agreed on a process that requires researchers to apply for access to HeLa genomic data and to acknowledge the family’s contributions.
  • Recognition of tissue ownership: The question of whether patients have property rights in their own cells remains legally unsettled. Cases like Moore v. Regents of the University of California (1990) established that individuals do not own excised tissue once it is removed, but the HeLa story continues to challenge that legal view. Some states have since enacted laws to address the issue, but federal law has not kept pace.

Ongoing Debates: The Legacy of HeLa Today

The ethical debates sparked by Henrietta Lacks are more relevant than ever. With the rise of biobanks, genetic testing, and patient data mining, issues of consent, privacy, and compensation are at the forefront of public discourse. For instance, the use of deidentified tissue samples in research is still allowed without explicit consent in many cases, a practice criticized by bioethicists as a continuation of the same problem. Recent scandals involving the misuse of genetic data by companies like 23andMe show that the public remains wary of how their biological information is handled.

Moreover, the racial dimensions of the story cannot be ignored. Henrietta Lacks was a Black woman treated at a time when racial segregation was still legal. Her exploitation reflects the long history of medical abuse of African Americans, from the Tuskegee syphilis study to forced sterilizations. Addressing these historical injustices requires ongoing effort to build trust between marginalized communities and the medical establishment. Today, many bioethicists call for policies that specifically address the legacy of racism in research and that ensure equitable access to the benefits of scientific progress.

Henrietta Lacks’ Legacy Today

Henrietta Lacks is now recognized as an unwitting but foundational contributor to modern medicine. Her cells have been used in over 110,000 scientific publications and are still cultivated and shipped around the world. But beyond the science, her story has become a powerful symbol of the need for ethical integrity in research.

In 2019, the World Health Organization (WHO) presented a posthumous award to Henrietta Lacks in recognition of her contributions to medicine. The Henrietta Lacks Memorial Garden was established at Johns Hopkins University, and in 2020, the university announced a new commemorative effort including a building named in her honor and a bioethics symposium. In 2023, the University of Bristol also unveiled a plaque honoring her contribution. These efforts seek to remedy the past by ensuring that her name is spoken with respect and that her descendants are included in the narrative.

The Lacks family continues to advocate for justice and to educate the public about bioethics and informed consent. They have spoken at universities and conferences around the world, sharing Henrietta’s story and calling for policies that protect patients from exploitation. The family also works with researchers to ensure that future studies involving HeLa cells are conducted ethically. As science marches forward, the lesson of Henrietta Lacks endures: human dignity must never be sacrificed for the sake of discovery.

Henrietta Lacks’ immortal cells have saved countless lives, but her story also reminds us that scientific progress must never come at the cost of human dignity. By learning from her legacy, we can build a future where research advances hand in hand with respect for the individuals who make it possible.

Summary of Key Points:

  • Henrietta Lacks’ cancer cells, taken without her knowledge in 1951, became the first immortal human cell line (HeLa cells).
  • HeLa cells contributed to the polio vaccine, cancer treatments, HIV/AIDS research, and genetic science.
  • The lack of informed consent and the commercialization of her cells without family knowledge raised serious ethical questions.
  • The case led to major reforms in medical ethics, including the Belmont Report and strengthened informed consent regulations.
  • Henrietta Lacks is remembered through the Henrietta Lacks Foundation, NIH data governance agreements, and public commemorations.
  • Her story continues to influence debates on patient rights, privacy, and racial justice in medical research.